# ObsEva SA (OBSV)

Source: https://www.quantisnow.com/company/OBSV
Generated: 2026-11-19T18:09:17.719Z

- Ticker: OBSV
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2017
- Website: obseva.com

## About

ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. The company is developing Linzagolix, an oral gonadotropin-releasing hormone receptor antagonist for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. It also is developing Ebopiprant, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. The company was founded in 2012 and is headquartered in Geneva, Switzerland.

## Latest OBSV news and filings

- 2023-04-26 11:00 UTC [SEC Form 15-12G filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-obseva-sa-4384986)
- 2023-04-17 21:00 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-obseva-sa-4344850)
- 2023-04-11 20:02 UTC [SEC Form 4] [SEC Form 4 filed by Loumaye Ernest](https://www.quantisnow.com/insight/sec-form-4-filed-by-loumaye-ernest-4322694)
- 2023-04-11 20:01 UTC [SEC Form 8-K] [ObsEva SA filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities](https://www.quantisnow.com/insight/obseva-sa-filed-sec-form-8-k-entry-into-a-material-4322685)
- 2023-03-31 20:01 UTC [SEC Form 10-K] [SEC Form 10-K filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-obseva-sa-4281439)
- 2023-03-31 20:01 UTC [ObsEva Files Year End 2022 Financial Statements](https://www.quantisnow.com/insight/obseva-files-year-end-2022-financial-statements-4281298)
- 2023-03-30 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-effect-filed-by-obseva-sa-4268782)
- 2023-03-30 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-effect-filed-by-obseva-sa-4268772)
- 2023-03-30 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-effect-filed-by-obseva-sa-4268754)
- 2023-03-30 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-effect-filed-by-obseva-sa-4268700)
- 2023-03-30 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-effect-filed-by-obseva-sa-4268694)
- 2023-03-30 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-effect-filed-by-obseva-sa-4268684)
- 2023-03-30 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-effect-filed-by-obseva-sa-4268680)
- 2023-03-28 20:42 UTC [SEC Form POS AM filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-obseva-sa-4260291)
- 2023-03-28 20:41 UTC [SEC Form POS AM filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-obseva-sa-4260279)
- 2023-03-28 20:41 UTC [SEC Form POS AM filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-obseva-sa-4260259)
- 2023-03-28 20:39 UTC [SEC Form POS AM filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-obseva-sa-4260257)
- 2023-03-28 20:38 UTC [SEC Form POS AM filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-obseva-sa-4260244)
- 2023-03-28 20:37 UTC [SEC Form POS AM filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-obseva-sa-4260235)
- 2023-03-28 20:36 UTC [SEC Form POS AM filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-obseva-sa-4260208)
- 2023-03-28 20:34 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-obseva-sa-4260185)
- 2023-03-28 20:32 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-obseva-sa-4260163)
- 2023-03-28 20:31 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-obseva-sa-4260160)
- 2023-03-28 20:30 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-obseva-sa-4260125)
- 2023-03-27 20:20 UTC [SEC Form 25 filed by ObsEva SA](https://www.quantisnow.com/insight/sec-form-25-filed-by-obseva-sa-4253360)
- 2023-03-22 21:23 UTC [SEC Form 8-K] [ObsEva SA filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/obseva-sa-filed-sec-form-8-k-other-events-4237254)
- 2023-03-15 11:30 UTC [SEC Form 8-K] [ObsEva SA filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/obseva-sa-filed-sec-form-8-k-notice-of-delisting-or-4203242)
- 2023-03-15 11:05 UTC [Market Insight] [ObsEva Announced Its Shares Will Be Delisted From The Nasdaq Stock Market effective March 23, 2023](https://www.quantisnow.com/insight/obseva-announced-its-shares-will-be-delisted-from-the-nasdaq-4203079)
- 2023-03-15 11:00 UTC [ObsEva Announces Progress Towards its Plans to Consolidate Operations in Switzerland: Delisting of OBSV from The Nasdaq Stock Market effective March 23, 2023](https://www.quantisnow.com/insight/obseva-announces-progress-towards-its-plans-to-consolidate-operations-in-4202986)
- 2023-03-15 07:40 UTC [Market Chatter] [ObsEva Will Delist From Nasdaq Effective March 23; To Maintain SIX Swiss Exchange Listing](https://www.quantisnow.com/insight/obseva-will-delist-from-nasdaq-effective-march-23-to-maintain-4202604)
- 2023-03-13 12:19 UTC [Market Insight] [Why Provention Bio Shares Are Trading Higher By Over 260%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-provention-bio-shares-are-trading-higher-by-over-260-4190800)
- 2023-03-13 11:14 UTC [Market Chatter] [ObsEva Names Ernest Loumaye As Interim Chairman Following Resignation Of Annette Clancy; Appoints Fabien de Ladonchamps As CEO](https://www.quantisnow.com/insight/obseva-names-ernest-loumaye-as-interim-chairman-following-resignation-of-4190252)
- 2023-03-13 11:13 UTC [Market Chatter] [Obseva Appoints Fabien De Ladonchamps As CEO Effective On Or About May 1; Also Names Ernest Loumayes As Interim Chairman Following The Resignation Of Annette Clancy](https://www.quantisnow.com/insight/obseva-appoints-fabien-de-ladonchamps-as-ceo-effective-on-or-4190247)
- 2023-03-13 11:05 UTC [SEC Form 8-K] [ObsEva SA filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/obseva-sa-filed-sec-form-8-k-leadership-update-regulation-fd-4190213)
- 2023-03-13 11:00 UTC [Leadership Update] [ObsEva Announces Update Towards its Strategic Reorganization to Consolidate Operations in Switzerland](https://www.quantisnow.com/insight/obseva-announces-update-towards-its-strategic-reorganization-to-consolidate-operations-4190086)
- 2023-03-08 18:28 UTC [Market Insight] [Why Miromatrix Medical Shares Are Trading Lower By 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session](https://www.quantisnow.com/insight/why-miromatrix-medical-shares-are-trading-lower-by-40-here-4173860)
- 2023-03-08 12:57 UTC [Market Insight] [Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-rigel-pharmaceuticals-shares-are-trading-higher-by-over-30-4171494)
- 2023-03-07 18:02 UTC [Market Insight] [Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session](https://www.quantisnow.com/insight/why-rivian-automotive-shares-are-trading-lower-by-over-10-4167300)
- 2023-03-06 18:25 UTC [Market Insight] [Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session](https://www.quantisnow.com/insight/why-aclaris-therapeutics-shares-are-trading-lower-by-around-55-4163373)
- 2023-03-06 13:52 UTC [Market Insight] [Earnings Scheduled For March 6, 2023](https://www.quantisnow.com/insight/earnings-scheduled-for-march-6-2023-4162214)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/OBSV
- Earnings history: https://www.quantisnow.com/earnings/OBSV
- Dividend history: https://www.quantisnow.com/dividends/OBSV
- Insider transactions: https://www.quantisnow.com/insiders/OBSV
- Options chain: https://www.quantisnow.com/options/OBSV
- SEC 8-K filings only: https://www.quantisnow.com/company/OBSV/8-k
- RSS and alerts for OBSV: https://www.quantisnow.com/docs/rss-feeds.md
